![]() |
市場調查報告書
商品編碼
2032564
心臟心律調節器市場:按類型、技術、適應症、最終用戶和地區分類(2026-2034 年)Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2026-2034 |
||||||
2025年全球心臟節律器市場規模達53億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到71億美元,2026年至2034年的複合年成長率為3.16%。心血管疾病(CVD)盛行率的上升、健康保險覆蓋範圍的用戶以及旨在改進外科技術的廣泛研發活動是推動市場成長的主要因素。
心臟節律器是一種植入胸部或腹部的小型醫療設備,它利用電脈衝治療異常心率,輔助調節和監測心率。它由電子和機械組件構成,例如微處理器、感測器、電極、導線、導線束和外殼,並可根據患者需求進行客製化。它有助於降低心律不整或心搏過緩引起的併發症風險,例如中風和心臟衰竭。此外,心臟節律器還整合到植入式心臟整流去顫器)和心臟再同步治療(CRT)裝置中,以提供更全面的治療方案。目前,領先的製造商正在推出小型、微創的心臟心律調節器,以減輕患者負擔並簡化手術植入過程。
心血管疾病(CVD)在一般人群中的高發生率是推動全球心臟節律器需求成長的主要動力。此外,老年人口的不斷成長,尤其是那些更容易患上心律不整、先天性心臟疾病和心房顫動等疾病的老年人,也促進了市場成長。人們健康意識的提高以及對心臟疾病治療方案的更深入了解,也對市場產生了積極影響。此外,越來越多的人加入醫療保險計劃,享受心律調節器費用補貼並降低整體醫療支出,這也促進了市場成長。領先的製造商正在推出電池續航時間更長、具備遠端監測功能的心律調節器,使醫療專業人員能夠使用智慧型手機遠端追蹤設備性能和患者的心臟功能。主要公司也致力於在心律調節器製造中使用生物相容性材料,以最大限度地降低感染疾病和其他與心律調節器植入相關的併發症的風險。最後,將無線技術整合到心律調節器中,實現了設備與植入者之間的資料傳輸和接收,提高了設備的精度和可靠性,進一步推動了市場成長。此外,許多國家的監管機構正在投資研發活動,以改善外科手術技術並促進人們獲得醫療服務。
The global cardiac pacemaker market size reached USD 5.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.16% during 2026-2034. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.
A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.
The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.